In a filing, Vera Therapeutics Inc revealed its PRESIDENT AND CEO Fordyce Marshall unloaded Company’s shares for reported $0.73 million on Jan 08 ’25. In the deal valued at $41.74 per share,17,500 shares were sold. As a result of this transaction, Fordyce Marshall now holds 143,603 shares worth roughly $5.32 million.
Then, MARSHALL FORDYCE bought 17,500 shares, generating $736,750 in total proceeds.
Before that, Fordyce Marshall sold 17,500 shares. Vera Therapeutics Inc shares valued at $753,680 were divested by the PRESIDENT AND CEO at a price of $43.07 per share. As a result of the transaction, Fordyce Marshall now holds 85,942 shares, worth roughly $3.18 million.
Wells Fargo initiated its Vera Therapeutics Inc [VERA] rating to an Overweight in a research note published on November 21, 2024; the price target was $70. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in mid October with a ‘”a Sector outperform”‘ rating. Oppenheimer began covering VERA with “an Outperform” recommendation on January 25, 2024. Cantor Fitzgerald started covering the stock on January 08, 2024. It rated VERA as “an Overweight”.
Price Performance Review of VERA
On Friday, Vera Therapeutics Inc [NASDAQ:VERA] saw its stock fall -12.25% to $37.02. Over the last five days, the stock has lost -12.27%. Vera Therapeutics Inc shares have fallen nearly -12.46% since the year began. Nevertheless, the stocks have risen 92.51% over the past one year. While a 52-week high of $51.61 was reached on 01/06/25, a 52-week low of $14.20 was recorded on 01/10/25. SMA at 50 days reached $45.26, while 200 days put it at $40.69.
Levels Of Support And Resistance For VERA Stock
The 24-hour chart illustrates a support level at 35.23, which if violated will result in even more drops to 33.44. On the upside, there is a resistance level at 40.37. A further resistance level may holdings at 43.71. The Relative Strength Index (RSI) on the 14-day chart is 25.95, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.43, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 97.22%. Stochastics %K at 25.77% indicates the stock is a holding.
How much short interest is there in Vera Therapeutics Inc?
A steep rise in short interest was recorded in Vera Therapeutics Inc stocks on 2024-12-13, growing by 0.25 million shares to a total of 6.8 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 6.55 million shares. There was a rise of 3.7%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on December 18, 2023 when Raymond James began covering the stock and recommended ‘”an Outperform”‘ rating along with a $29 price target.
